These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33728863)

  • 1. Tripartite motif-containing protein 6 facilitates growth and migration of breast cancer through degradation of STUB1.
    Wei C; Wu J; Liu W; Lu J; Li H; Hai B
    Eur J Histochem; 2021 Mar; 65(1):. PubMed ID: 33728863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STUB1 suppresseses tumorigenesis and chemoresistance through antagonizing YAP1 signaling.
    Tang DE; Dai Y; Lin LW; Xu Y; Liu DZ; Hong XP; Jiang HW; Xu SH
    Cancer Sci; 2019 Oct; 110(10):3145-3156. PubMed ID: 31393050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1.
    Zheng S; Zhou C; Wang Y; Li H; Sun Y; Shen Z
    J Exp Clin Cancer Res; 2020 Jan; 39(1):23. PubMed ID: 31992359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E3 ligase TRIM22 functions as a tumor suppressor in breast cancer by targeting CCS for proteasomal degradation to inhibit STAT3 signaling.
    Yang Y; Hao X; Zhang J; Gao T; Huo M; Liu W; Hu T; Ma T; Yuan B; Zhang M; Teng X; Yu H; Huang W; Wang Y
    Cancer Lett; 2024 Sep; 600():217157. PubMed ID: 39127340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.
    Guo Y; Li Q; Zhao G; Zhang J; Yuan H; Feng T; Ou D; Gu R; Li S; Li K; Lin P
    Cell Death Dis; 2021 Oct; 12(10):945. PubMed ID: 34650049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM28 promotes tumor growth and metastasis in breast cancer by targeting the BRD7 protein for ubiquitination and degradation.
    Xue C; Meng H; Niu W; Li M; Wei J; Chen S; Zheng L; Duan Y; Deng H; Tang F; Fan S; Tan M; Xiong W; Zhou M
    Cell Oncol (Dordr); 2024 Oct; 47(5):1973-1993. PubMed ID: 39222175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells.
    Li X; Jiang J; Wu Q; You T; Yang F
    Cancer Gene Ther; 2024 Aug; 31(8):1186-1200. PubMed ID: 38714850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.
    Bharaj P; Atkins C; Luthra P; Giraldo MI; Dawes BE; Miorin L; Johnson JR; Krogan NJ; Basler CF; Freiberg AN; Rajsbaum R
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tripartite motif protein 6 promotes hepatocellular carcinoma progression via multiple pathways.
    Zhang Y; Yuan L; Cui S; Wu S
    Turk J Med Sci; 2023; 53(5):1032-1044. PubMed ID: 38813007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel oncogene TRIM63 promotes cell proliferation and migration via activating Wnt/β-catenin signaling pathway in breast cancer.
    Li K; Pan W; Ma Y; Xu X; Gao Y; He Y; Wei L; Zhang J
    Pathol Res Pract; 2019 Oct; 215(10):152573. PubMed ID: 31399258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM6 Reduces Ferroptosis and Chemosensitivity by Targeting SLC1A5 in Lung Cancer.
    Zhang Y; Dong P; Liu N; Yang JY; Wang HM; Geng Q
    Oxid Med Cell Longev; 2023; 2023():9808100. PubMed ID: 36654781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
    Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L
    Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM6 interacts with Myc and maintains the pluripotency of mouse embryonic stem cells.
    Sato T; Okumura F; Ariga T; Hatakeyama S
    J Cell Sci; 2012 Mar; 125(Pt 6):1544-55. PubMed ID: 22328504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM16 overexpression inhibits the metastasis of colorectal cancer through mediating Snail degradation.
    Ruan L; Liu W; Yang Y; Chu Z; Yang C; Yang T; Sun J
    Exp Cell Res; 2021 Sep; 406(1):112735. PubMed ID: 34265287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM6 silencing for inhibiting growth and angiogenesis of gliomas by regulating VEGFA.
    Liu X; Zhao J; Dong P; Du X; Lu W; Feng Y; Wang L
    J Chem Neuroanat; 2023 Oct; 132():102291. PubMed ID: 37236551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM65/NF2/YAP1 Signaling Coordinately Orchestrates Metabolic and Immune Advantages in Hepatocellular Carcinoma.
    Bian Z; Xu C; Wang X; Zhang B; Xiao Y; Liu L; Zhao S; Huang N; Yang F; Zhang Y; Xue S; Wang X; Pan Q; Sun F
    Adv Sci (Weinh); 2024 Sep; 11(35):e2402578. PubMed ID: 39005234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
    Zheng L; Zhao Z; Rong L; Xue L; Song Y
    J Genet Genomics; 2019 Oct; 46(10):477-488. PubMed ID: 31812473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDLIM5 inhibits STUB1-mediated degradation of SMAD3 and promotes the migration and invasion of lung cancer cells.
    Shi Y; Wang X; Xu Z; He Y; Guo C; He L; Huan C; Cai C; Huang J; Zhang J; Li Y; Zeng C; Zhang X; Wang L; Ke Y; Cheng H
    J Biol Chem; 2020 Oct; 295(40):13798-13811. PubMed ID: 32737199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIM65 supports bladder urothelial carcinoma cell aggressiveness by promoting ANXA2 ubiquitination and degradation.
    Wei WS; Chen X; Guo LY; Li XD; Deng MH; Yuan GJ; He LY; Li YH; Zhang ZL; Jiang LJ; Chen RX; Ma XD; Wei S; Ma NF; Liu ZW; Luo JH; Zhou FJ; Xie D
    Cancer Lett; 2018 Oct; 435():10-22. PubMed ID: 30075204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
    Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
    J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.